Sense Biodetection Limited

Sense Biodetection Limited is a molecular diagnostics company focused on bringing tests to the True Point-of-Careâ„¢. Sense was founded in 2014 by Harry Lamble and Ralph Lamble, who combined their respective expertise in molecular sciences and medical device design to realize their vision of empowering patients through decentralised testing. Sense has developed a new class of diagnostic product to break down the barriers that have led to the current model of centralized testing. Sense products are simple, ultra-rapid, handheld tests which remove the need for advanced hardware to determine a result. Sense operates from bespoke laboratory, development and manufacturing facilities in Cambridge and Oxford, UK and is growing rapidly as it takes its first products to market.